China Biotech Services Holdings Limited (8037.HK)
HKD 0.49
(6.52%)
HKD 0.49
(6.52%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -73.45 Million HKD | -107.48% |
| 2022 | 936.9 Million HKD | 253.38% |
| 2021 | 255.32 Million HKD | 6.9% |
| 2020 | 249.63 Million HKD | 522.64% |
| 2019 | -86.31 Million HKD | 3.51% |
| 2018 | -57.52 Million HKD | -109.1% |
| 2017 | -66.17 Million HKD | 48.64% |
| 2016 | -86.26 Million HKD | -51.64% |
| 2015 | -55.57 Million HKD | -15.92% |
| 2014 | -71.87 Million HKD | -90.42% |
| 2013 | -16.43 Million HKD | -69.17% |
| 2012 | -10.19 Million HKD | 76.63% |
| 2011 | -38.88 Million HKD | -316.12% |
| 2010 | -12.09 Million HKD | 74.89% |
| 2009 | -74.81 Million HKD | -38.26% |
| 2008 | -27.16 Million HKD | 8.91% |
| 2007 | -31.58 Million HKD | -802.83% |
| 2006 | 4.49 Million HKD | -84.09% |
| 2005 | 28.24 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -43.99 Million HKD | 0.0% |
| 2024 Q1 | -43.99 Million HKD | 27.36% |
| 2023 Q2 | -34.25 Million HKD | -2953.03% |
| 2023 FY | - HKD | -107.48% |
| 2023 Q3 | -54.39 Million HKD | -58.79% |
| 2023 Q4 | -79.73 Million HKD | -46.59% |
| 2023 Q1 | -1.12 Million HKD | -100.4% |
| 2022 Q2 | 117.16 Million HKD | -10.82% |
| 2022 Q4 | 282.9 Million HKD | -9.41% |
| 2022 FY | - HKD | 253.38% |
| 2022 Q1 | 131.38 Million HKD | 1216.89% |
| 2022 Q3 | 312.28 Million HKD | 166.53% |
| 2021 FY | - HKD | 6.9% |
| 2021 Q4 | 9.97 Million HKD | -69.0% |
| 2021 Q1 | 38.86 Million HKD | 57.26% |
| 2021 Q2 | 108.41 Million HKD | 178.96% |
| 2021 Q3 | 32.17 Million HKD | -70.32% |
| 2020 Q3 | 222.05 Million HKD | 1128.0% |
| 2020 FY | - HKD | 522.64% |
| 2020 Q2 | -21.6 Million HKD | 12.08% |
| 2020 Q1 | -24.57 Million HKD | -30.9% |
| 2020 Q4 | 24.71 Million HKD | -88.87% |
| 2019 Q4 | -18.77 Million HKD | 16.25% |
| 2019 Q1 | -14.53 Million HKD | 29.08% |
| 2019 FY | - HKD | 3.51% |
| 2019 Q2 | -21.49 Million HKD | -47.94% |
| 2019 Q3 | -22.41 Million HKD | -4.26% |
| 2018 Q4 | -20.48 Million HKD | 0.19% |
| 2018 FY | - HKD | -109.1% |
| 2018 Q3 | -20.52 Million HKD | -50.75% |
| 2018 Q2 | -13.61 Million HKD | -5.28% |
| 2018 Q1 | -12.93 Million HKD | 25.3% |
| 2017 FY | - HKD | 48.64% |
| 2017 Q4 | -17.31 Million HKD | -298.83% |
| 2017 Q3 | -4.34 Million HKD | 30.14% |
| 2017 Q2 | -6.21 Million HKD | 18.78% |
| 2017 Q1 | -7.65 Million HKD | 75.26% |
| 2016 Q2 | -8.27 Million HKD | 19.95% |
| 2016 Q3 | -12.89 Million HKD | -55.81% |
| 2016 Q1 | -10.33 Million HKD | 17.44% |
| 2016 FY | - HKD | -51.64% |
| 2016 Q4 | -30.92 Million HKD | -139.85% |
| 2015 FY | - HKD | -15.92% |
| 2015 Q3 | -8.23 Million HKD | 55.07% |
| 2015 Q1 | -2.96 Million HKD | 80.55% |
| 2015 Q4 | -12.51 Million HKD | -51.98% |
| 2015 Q2 | -18.33 Million HKD | -518.25% |
| 2014 Q1 | -8 Million HKD | 2.9% |
| 2014 FY | - HKD | -90.42% |
| 2014 Q4 | -15.24 Million HKD | -892.0% |
| 2014 Q2 | -9.06 Million HKD | -13.14% |
| 2014 Q3 | -1.53 Million HKD | 83.04% |
| 2013 Q4 | -8.24 Million HKD | -1840.52% |
| 2013 FY | - HKD | -69.17% |
| 2013 Q1 | -5.07 Million HKD | -8.17% |
| 2013 Q2 | 6.05 Million HKD | 219.38% |
| 2013 Q3 | -425 Thousand HKD | -107.02% |
| 2012 Q4 | -4.68 Million HKD | -121.9% |
| 2012 Q2 | -34.78 Million HKD | -146.28% |
| 2012 FY | - HKD | 76.63% |
| 2012 Q1 | -14.12 Million HKD | -189.9% |
| 2012 Q3 | 21.4 Million HKD | 161.56% |
| 2011 FY | - HKD | -316.12% |
| 2011 Q1 | 3.94 Million HKD | 576.21% |
| 2011 Q2 | -4.46 Million HKD | -213.19% |
| 2011 Q3 | -40.99 Million HKD | -818.53% |
| 2011 Q4 | 15.7 Million HKD | 138.32% |
| 2010 Q4 | -828 Thousand HKD | 0.0% |
| 2010 FY | - HKD | 74.89% |
| 2010 Q1 | -899 Thousand HKD | 0.0% |
| 2009 FY | - HKD | -38.26% |
| 2009 Q1 | -2.38 Million HKD | 0.0% |
| 2008 FY | - HKD | 8.91% |
| 2007 FY | - HKD | -802.83% |
| 2006 FY | - HKD | -84.09% |
| 2005 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Life Healthcare Group Limited | 27.68 Million HKD | 365.299% |